DIAGNOS (OTCMKTS:DGNOF) Issues Earnings Results

DIAGNOS (OTCMKTS:DGNOFGet Free Report) released its quarterly earnings data on Thursday. The company reported ($0.01) earnings per share for the quarter, meeting the consensus estimate of ($0.01), Zacks reports.

DIAGNOS Stock Performance

DGNOF traded down $0.00 during trading on Thursday, hitting $0.14. The stock had a trading volume of 107,500 shares, compared to its average volume of 100,062. The company has a 50 day moving average price of $0.16 and a 200-day moving average price of $0.20. The firm has a market cap of $16.27 million, a price-to-earnings ratio of -3.38 and a beta of -0.09. The company has a debt-to-equity ratio of 0.20, a current ratio of 1.75 and a quick ratio of 1.75. DIAGNOS has a one year low of $0.13 and a one year high of $0.29.

DIAGNOS Company Profile

(Get Free Report)

DIAGNOS Inc provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence.

Read More

Earnings History for DIAGNOS (OTCMKTS:DGNOF)

Receive News & Ratings for DIAGNOS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DIAGNOS and related companies with MarketBeat.com's FREE daily email newsletter.